Danielle Mapes – Trademark Portfolio

Entity Type: 01

Danielle Mapes holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include DEAL-A-DAY PIPELINE and THE REAL ESTATE PRESCRIPTION. The owner is based in Ann Arbor, MI.

2144 S State St.

Ann Arbor, MI 48104

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Danielle Mapes's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Danielle Mapes have?

Danielle Mapes has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Danielle Mapes file in?

Danielle Mapes files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are Danielle Mapes's most well-known trademarks?

Danielle Mapes's registered trademark portfolio includes well-known marks such as DEAL-A-DAY PIPELINE and THE REAL ESTATE PRESCRIPTION. These are among 2 currently registered trademarks in the portfolio.

What is Danielle Mapes's trademark registration success rate?

Danielle Mapes has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.